Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY

More Jobs >>

Events

Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA

More Events >>

Caliber Biotherapeutics News

Most Popular Caliber Biotherapeutics Story

Caliber opens new TX manufacturing facility

April 28, 2011 — 6:57am ET | By Erica Teichert

Caliber Biotherapeutics has opened the world's largest plant-made pharmaceutical manufacturing facility in its base, Bryan, TX. The company is also planning to develop cell- and microbial-based Read more...

Caliber Biotherapeutics Press Releases

New Biopharmaceutical Company, Caliber Biotherapeutics to Accelerate Delivery of Vaccines and Protein Therapeutics

Latest Headlines

Caliber opens new TX manufacturing facility
April 28, 2011

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK